Etomidate Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Etomidate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Oct 5, 2022.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-6695-02
Dosage Form
Injection
Presentation
Amidate, Injection, 2 mg/mL (NDC 0409-6695-02)
Initial Posting
Oct 5, 2022

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.